CA2253238C - Novel agouti-related gene - Google Patents

Novel agouti-related gene Download PDF

Info

Publication number
CA2253238C
CA2253238C CA002253238A CA2253238A CA2253238C CA 2253238 C CA2253238 C CA 2253238C CA 002253238 A CA002253238 A CA 002253238A CA 2253238 A CA2253238 A CA 2253238A CA 2253238 C CA2253238 C CA 2253238C
Authority
CA
Canada
Prior art keywords
art
polypeptide
seq
nucleic acid
acid molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002253238A
Other languages
English (en)
French (fr)
Other versions
CA2253238A1 (en
Inventor
Kevin Lee Stark
Roland Luethy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of CA2253238A1 publication Critical patent/CA2253238A1/en
Application granted granted Critical
Publication of CA2253238C publication Critical patent/CA2253238C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
CA002253238A 1996-05-10 1997-04-22 Novel agouti-related gene Expired - Fee Related CA2253238C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1750596P 1996-05-10 1996-05-10
US60/017,505 1996-11-27
US08/757,541 1996-11-27
US08/757,541 US5766877A (en) 1996-05-10 1996-11-27 Genes encoding art, an agouti-related transcript
PCT/US1997/006853 WO1997043412A1 (en) 1996-05-10 1997-04-22 Novel agouti-related gene

Publications (2)

Publication Number Publication Date
CA2253238A1 CA2253238A1 (en) 1997-11-20
CA2253238C true CA2253238C (en) 2008-08-12

Family

ID=26689965

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002253238A Expired - Fee Related CA2253238C (en) 1996-05-10 1997-04-22 Novel agouti-related gene

Country Status (12)

Country Link
US (5) US5766877A (https=)
EP (1) EP0917571B1 (https=)
JP (1) JP4219404B2 (https=)
AT (1) ATE283917T1 (https=)
AU (1) AU2681497A (https=)
CA (1) CA2253238C (https=)
DE (1) DE69731834T2 (https=)
DK (1) DK0917571T3 (https=)
ES (1) ES2234015T3 (https=)
PT (1) PT917571E (https=)
SI (1) SI0917571T1 (https=)
WO (1) WO1997043412A1 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6310034B1 (en) 1993-05-21 2001-10-30 Ut-Battelle, Llc Agouti polypeptide compositions
US5843652A (en) * 1993-05-21 1998-12-01 Lockheed Martin Energy Systems, Inc. Isolation and characterization of Agouti: a diabetes/obesity related gene
US5766877A (en) * 1996-05-10 1998-06-16 Amgen Inc. Genes encoding art, an agouti-related transcript
EP0942967A1 (en) * 1996-11-06 1999-09-22 Children's Medical Center Corporation Transgenic animal expressing a syndecan in the regions of hypothalamus
DE69838104T2 (de) * 1997-12-16 2008-04-10 Merck & Co., Inc. C-terminale region des "agouti-related-transcript"-proteins (art)
US6878520B1 (en) * 1997-12-16 2005-04-12 Merck & Co., Inc. C-terminal region of agouti-related transcript (ART) protein
WO1999050295A2 (en) * 1998-03-30 1999-10-07 Gryphon Sciences Agouti-related protein analogs and methods of use
US6689873B1 (en) 1998-04-29 2004-02-10 Merck & Co., Inc. Nucleic acid encoding rat agouti related protein
CA2340323A1 (en) * 1998-09-03 2000-03-16 Ronald Duman Mc4-r as target for the identification of compounds used to treat drug addiction
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
US6603058B1 (en) 1998-12-09 2003-08-05 Oklahoma Medical Research Foundation Non-human animal model for obesity and uses thereof
US6303749B1 (en) * 1999-01-29 2001-10-16 Amgen Inc. Agouti and agouti-related peptide analogs
US20030064921A1 (en) * 1999-10-27 2003-04-03 The Regents Of The University Of California Methods and compounds for modulating melanocortin receptor ligand binding and activity
EP1125579A3 (en) 2000-01-18 2003-01-02 Pfizer Products Inc. Uses of agrp-melanocortin receptor binding modulating compounds
MXPA02011836A (es) * 2000-05-31 2003-05-14 Du Pont Catalizadores para la polimerizacion de olefinas.
AU2002238106A1 (en) * 2001-02-13 2002-08-28 Palatin Technologies, Inc. Melanocortin metallopeptides for treatment of sexual dysfunction
ATE348097T1 (de) 2001-04-09 2007-01-15 Chiron Corp Guanidinoverbindungen als melanocortin-4-rezeptor (mc4-r) agonisten
US20030195187A1 (en) * 2002-02-04 2003-10-16 Chiron Corporation Guanidino compounds
US20050124652A1 (en) * 2002-02-04 2005-06-09 Rustum Boyce Guanidino compounds
US20030207814A1 (en) * 2002-02-04 2003-11-06 Chiron Corporation Novel guanidinyl derivatives
EP1487474A4 (en) * 2002-02-25 2006-11-29 Chiron Corp INTRANASAL ADMINISTRATION OF MC4-R AGONISTS
WO2003099818A1 (en) * 2002-05-23 2003-12-04 Chiron Corporation Substituted quinazolinone compounds
JP2006506968A (ja) * 2002-07-03 2006-03-02 メルク　エンド　カムパニー　インコーポレーテッド アグーチ関連蛋白質欠損細胞、非ヒトトランスジェニック動物及びエネルギー代謝を調節する化合物の選択方法
JP2007501861A (ja) * 2003-05-23 2007-02-01 カイロン コーポレイション Ｍｃ４−ｒアゴニストとしてのグアニジノ置換キナゾリノン化合物
ES2391457T3 (es) * 2003-08-13 2012-11-26 Sandoz Ag Procedimiento para la purificación de polipéptidos recombinantes
WO2005051391A1 (en) * 2003-11-19 2005-06-09 Chiron Corporation Quinazolinone compounds with reduced bioaccumulation
US6974187B2 (en) * 2004-01-28 2005-12-13 Tachi-S Co., Ltd. Vehicle seat structure
NZ550114A (en) * 2004-04-20 2011-02-25 Transtech Pharma Inc Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US20070021433A1 (en) 2005-06-03 2007-01-25 Jian-Qiang Fan Pharmacological chaperones for treating obesity
US7833927B2 (en) * 2005-08-31 2010-11-16 Rohm And Haas Company Single site palladium catalyst complexes
US8563742B2 (en) * 2008-08-29 2013-10-22 High Point Pharmaceuticals, Llc Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
WO2012100342A1 (en) 2011-01-27 2012-08-02 Université de Montréal Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4263428A (en) * 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
EP0052322B1 (de) * 1980-11-10 1985-03-27 Gersonde, Klaus, Prof. Dr. Verfahren zur Herstellung von Lipid-Vesikeln durch Ultraschallbehandlung, Anwendung des Verfahrens und Vorrichtung zur Durchführung des Verfahrens
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
DE3374837D1 (en) * 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
EP0143949B1 (en) * 1983-11-01 1988-10-12 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Pharmaceutical composition containing urokinase
EP0154316B1 (en) * 1984-03-06 1989-09-13 Takeda Chemical Industries, Ltd. Chemically modified lymphokine and production thereof
EP0401384B1 (en) * 1988-12-22 1996-03-13 Kirin-Amgen, Inc. Chemically modified granulocyte colony stimulating factor
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5766877A (en) * 1996-05-10 1998-06-16 Amgen Inc. Genes encoding art, an agouti-related transcript

Also Published As

Publication number Publication date
PT917571E (pt) 2005-04-29
DE69731834T2 (de) 2005-12-15
US6060589A (en) 2000-05-09
WO1997043412A1 (en) 1997-11-20
ATE283917T1 (de) 2004-12-15
ES2234015T3 (es) 2005-06-16
US7122520B2 (en) 2006-10-17
AU2681497A (en) 1997-12-05
DK0917571T3 (da) 2005-03-14
SI0917571T1 (en) 2005-06-30
EP0917571A1 (en) 1999-05-26
EP0917571B1 (en) 2004-12-01
US20030082737A1 (en) 2003-05-01
US20010007752A1 (en) 2001-07-12
US6203995B1 (en) 2001-03-20
US5766877A (en) 1998-06-16
CA2253238A1 (en) 1997-11-20
DE69731834D1 (de) 2005-01-05
JP2001517931A (ja) 2001-10-09
JP4219404B2 (ja) 2009-02-04

Similar Documents

Publication Publication Date Title
CA2253238C (en) Novel agouti-related gene
EP1417227B1 (en) Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells
JP4793836B2 (ja) 線維芽細胞増殖因子様ポリペプチド
US5741772A (en) Neurotrophic factor NNT-1
CA2323525C (en) Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
JP3492999B2 (ja) 脂肪細胞特異的タンパク質の同族体
KR100334739B1 (ko) 절단된신경교세포주-유래신경영양성인자단백질산물
EP1390403B1 (en) Peptides derived from neural thread proteins and their medical use
AU4870599A (en) Delta-related polypeptides
KR20000010571A (ko) 신경교세포주-유래신경영양성인자수용체및이를코드하는핵산서열과아미노산서열_
KR20000029912A (ko) 뉴리틴,신경유전자
EP0546074A1 (en) Genetic material encoding igfbp-5
CA2279999C (en) The neurotrophic factor nnt-1
CA2323506C (en) Mammalian blood loss-induced gene, kd312
KR100399377B1 (ko) Ｇｄｎｆ 단백질의 분석방법 및 검정 기구
MXPA01000980A (en) Delta-related polypeptides
MXPA00009172A (en) Mammalian blood loss-induced gene, kd312
MXPA99001282A (en) Neuritin, a neurogene
HK1025125B (en) The neurotrophic factor nnt-1

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed